Persistent and Late-Onset Disseminated Intravascular Coagulation Are Closely Related to Poor Prognosis in Patients with Sepsis

弥漫性血管内凝血 医学 败血症 内科学 回顾性队列研究 重症监护医学 外科
作者
Tadashi Matsuoka,Kazuma Yamakawa,Toshiaki Iba,Koichiro Homma,Junichi Sasaki
出处
期刊:Thrombosis and Haemostasis [Thieme Medical Publishers (Germany)]
卷期号:124 (05): 399-407 被引量:5
标识
DOI:10.1055/a-2196-3630
摘要

Background Septic-associated disseminated intravascular coagulation (DIC) is heterogeneous regarding prognosis and responsiveness to anticoagulant therapy. Objectives To investigate the relationship between the timing of development and recovery of DIC, its prognosis, and the difference in response to anticoagulant therapy in sepsis-associated DIC patients. Methods This study was performed with a dataset from a multicenter nationwide retrospective cohort study (J-Septic DIC registry) in Japan between 2011 and 2013 to reveal the subgroup “high risk of death in DIC” and investigate the relationship between anticoagulant use and mortality. Patients were assigned to four groups based on the International Society on Thrombosis and Haemostasis-overt DIC status at days 1 and 3: non-DIC (−/−), early-recovered DIC (+/−), late-onset DIC (−/+), and persistent DIC (+/+). Results A total of 1,922 patients were included. In-hospital mortality in persistent and late-onset DIC patients was significantly higher than in patients with non-DIC and early-recovered DIC. This finding indicates that persistent DIC and late-onset DIC were a poor-prognosis subgroup, “high-risk” DIC. Meanwhile, patients with high-risk DIC treated with anticoagulants had significantly better outcomes than those without anticoagulants after adjusting for confounding factors. Conclusion This study showed that individuals with a high risk of death, persistent DIC, and late-onset DIC were a poor-prognostic subgroup in septic DIC; however, high-risk DIC is also a subgroup that can obtain more benefits from anticoagulant therapy.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
量子星尘发布了新的文献求助10
刚刚
不来也不去完成签到 ,获得积分10
1秒前
Eber完成签到,获得积分10
2秒前
Kelly1426完成签到,获得积分10
3秒前
freeway完成签到,获得积分10
4秒前
Owen应助张张采纳,获得10
5秒前
xcgh完成签到,获得积分10
5秒前
Ha完成签到,获得积分10
5秒前
123完成签到 ,获得积分10
5秒前
CooL完成签到 ,获得积分10
6秒前
chhzz完成签到 ,获得积分10
7秒前
金子完成签到,获得积分10
7秒前
QDDYR完成签到,获得积分10
7秒前
raibow9814完成签到,获得积分10
9秒前
言非离完成签到 ,获得积分10
10秒前
花开四海完成签到 ,获得积分10
12秒前
帅气的宽完成签到 ,获得积分10
13秒前
可靠的书本完成签到,获得积分10
13秒前
浮游应助小心翼翼采纳,获得30
14秒前
称心芷天完成签到 ,获得积分20
15秒前
复杂真完成签到,获得积分10
16秒前
不回首完成签到 ,获得积分10
16秒前
wisher完成签到 ,获得积分10
17秒前
向来缘浅关注了科研通微信公众号
17秒前
量子星尘发布了新的文献求助10
18秒前
巫马寒梅完成签到,获得积分10
20秒前
dididi完成签到 ,获得积分10
21秒前
十五完成签到,获得积分10
21秒前
黄油可颂完成签到 ,获得积分10
22秒前
爱学习的小钟完成签到 ,获得积分10
23秒前
木子完成签到,获得积分10
23秒前
swordshine完成签到,获得积分0
25秒前
qin完成签到,获得积分10
26秒前
27秒前
隔水一路秋完成签到,获得积分10
27秒前
totoro完成签到,获得积分10
28秒前
Jieh完成签到,获得积分10
28秒前
懒惰扼杀激情完成签到 ,获得积分10
29秒前
吴天春完成签到,获得积分10
29秒前
枫糖叶落完成签到,获得积分10
30秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Handbook of Milkfat Fractionation Technology and Application, by Kerry E. Kaylegian and Robert C. Lindsay, AOCS Press, 1995 1000
A novel angiographic index for predicting the efficacy of drug-coated balloons in small vessels 500
Textbook of Neonatal Resuscitation ® 500
The Affinity Designer Manual - Version 2: A Step-by-Step Beginner's Guide 500
Affinity Designer Essentials: A Complete Guide to Vector Art: Your Ultimate Handbook for High-Quality Vector Graphics 500
Optimisation de cristallisation en solution de deux composés organiques en vue de leur purification 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 内科学 生物化学 物理 计算机科学 纳米技术 遗传学 基因 复合材料 化学工程 物理化学 病理 催化作用 免疫学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 5079744
求助须知:如何正确求助?哪些是违规求助? 4297883
关于积分的说明 13389008
捐赠科研通 4121176
什么是DOI,文献DOI怎么找? 2257046
邀请新用户注册赠送积分活动 1261338
关于科研通互助平台的介绍 1195430